Evidence map›Paper›PMID 40901278›Full record

ArticlePublic health ethics2025

Privacy, Exploitation and Global Disease Surveillance: Can We Justly Prevent the Next Pandemic?

Anand Sergeant

Abstract read
In one paragraph

Article in Public health ethics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Anand SergeantDepartments of Philosophy and Continuing Education, University of Oxford, UK.ORCID https://orcid.org/0009-0000-0387-473X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In light of the COVID-19 pandemic, global health organizations have called for the implementation of robust global disease surveillance systems to recognize and respond to emerging pathogens. These active surveillance technologies would have a significant global benefit by preventing the spread of current pandemics and informing future pandemic responses. In this paper, I examine the extent to which we can sacrifice individuals' privacy through global disease surveillance in order to benefit current and future generations. First, I outline disease surveillance technologies and explain how disease surveillance would occur primarily in low-income, rural communities in the Global South. Next, I outline privacy-related harms that these individuals would experience as a result of disease surveillance. I argue that within our current distributional system for global health resources, pandemic surveillance would impose privacy-related burdens on marginalized communities, who would receive inadequate benefits from these programs. This is unfair because it exploits the worst off in order to benefit individuals in wealthy nations. I conclude that to justifiably implement global disease surveillance, we ought to adopt a 'prioritarian' approach to health distribution. To impose privacy-related burdens on the worst off, we must ensure that they benefit significantly.

Identifiers

PMID40901278
PMCPMC12400026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.